vTv Therapeutics (VTVT) Short Interest Ratio & Short Volume $14.27 +0.79 (+5.86%) As of 01/23/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends vTv Therapeutics Short Interest DatavTv Therapeutics (VTVT) has a short interest of 16,900 shares, representing 1.14% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 7,854 shares to cover all short positions.Current Short Interest16,900 sharesPrevious Short Interest16,900 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$233,389.00Short Interest Ratio0.6 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares3,190,000 sharesFloat Size1,480,000 sharesShort Percent of Float1.14%Today's Trading Volume10,028 sharesAverage Trading Volume7,854 sharesToday's Volume Vs. Average128% Short Selling vTv Therapeutics? Sign up to receive the latest short interest report for vTv Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVTVT Short Interest Over TimeVTVT Days to Cover Over TimeVTVT Percentage of Float Shorted Over Time vTv Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202416,900 shares $233,389.00 No Change1.1%0.6 $13.81 12/15/202416,900 shares $254,007.00 -24.9%1.1%0.6 $15.03 11/30/202422,500 shares $360,900.00 -17.3%1.6%0.7 $16.04 11/15/202427,200 shares $469,200.00 -5.9%1.9%0.9 $17.25 10/31/202428,900 shares $396,508.00 -0.3%2.2%1 $13.72 10/15/202429,000 shares $386,860.00 -7.9%2.3%1 $13.34 9/30/202431,500 shares $424,620.00 +1.6%2.4%1.1 $13.48 9/15/202431,000 shares $442,060.00 -6.3%2.4%1 $14.26 8/31/202433,100 shares $520,001.00 -13.1%2.6%1.2 $15.71 8/15/202438,100 shares $513,969.00 +34.6%3.0%1.5 $13.49 Get the Latest News and Ratings for VTVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202428,300 shares $429,028.00 +45.9%2.2%1.4 $15.16 7/15/202419,400 shares $473,166.00 -1.0%1.5%1.6 $24.39 6/30/202419,600 shares $346,136.00 -10.5%1.5%2.6 $17.66 6/15/202421,900 shares $460,338.00 +17.7%1.7%3.4 $21.02 5/31/202418,600 shares $433,938.00 -21.9%1.4%1.8 $23.33 5/15/202423,800 shares $615,944.00 -10.5%1.8%0.4 $25.88 4/30/202426,600 shares $742,140.00 -7.6%3.2%0.4 $27.90 4/15/202428,800 shares $720,000.00 -10.6%3.4%0.4 $25.00 3/31/202432,200 shares $757,666.00 -43.7%6.1%0.4 $23.53 3/15/202457,200 shares $1.03 million +50.5%10.9%0.8 $18.00 2/29/202438,000 shares $666,900.00 -12.0%8.4%0.5 $17.55 2/15/202443,200 shares $415,152.00 -39.1%6.5%1.4 $9.61 1/31/202470,900 shares $596,269.00 +78.6%10.7%2.2 $8.41 1/15/202439,700 shares $363,255.00 -20.8%6.0%1.5 $9.15 12/31/202350,100 shares $576,150.00 +27.8%N/A2.3 $11.50 12/15/202339,200 shares $343,000.00 +10.4%5.9%2 $8.75 11/30/202335,500 shares $507,295.00 +25.0%5.3%2.1 $14.29 11/15/202328,400 shares $398,736.00 -97.6%4.3%7.7 $14.04 10/31/20231,180,000 shares $484,980.00 -6.4%4.4%7.1 $0.41 10/15/20231,260,000 shares $587,286.00 +4.1%4.7%7.1 $0.47 9/30/20231,210,000 shares $578,380.00 -4.0%4.5%6.7 $0.48 9/15/20231,260,000 shares $560,826.00 +4.1%4.6%7.6 $0.45 8/31/20231,210,000 shares $617,100.00 -13.6%4.4%5.8 $0.51 8/15/20231,400,000 shares $998,760.00 +15.7%5.1%6.2 $0.71 7/31/20231,210,000 shares $817,960.00 -4.7%4.4%8.5 $0.68 7/15/20231,270,000 shares $915,670.00 -1.6%4.6%9.8 $0.72 6/30/20231,290,000 shares $954,342.00 +7.5%4.7%10.2 $0.74 6/15/20231,200,000 shares $911,880.00 -3.2%4.4%9.6 $0.76 5/31/20231,240,000 shares $979,600.00 +6.9%4.5%15.1 $0.79 5/15/20231,160,000 shares $996,208.00 -1.7%4.2%12.6 $0.86DeFi Coin on Verge of Breakout! (Ad)What Smart Crypto Investors Are Doing Differently in 2025 Free book reveals how to navigate and thrive in today’s crypto market… Request your FREE copy of Crypto Revolution now. 4/30/20231,180,000 shares $908,600.00 -0.8%4.3%13.4 $0.77 4/15/20231,190,000 shares $880,838.00 -0.8%4.4%13.6 $0.74 3/31/20231,200,000 shares $969,360.00 -1.6%4.4%12.2 $0.81 3/15/20231,220,000 shares $964,044.00 +8.9%4.5%11.5 $0.79 2/28/20231,120,000 shares $907,200.00 No Change4.1%10.3 $0.81 2/15/20231,120,000 shares $985,600.00 -4.3%4.1%17.3 $0.88 1/31/20231,170,000 shares $1.11 million +3.5%4.3%16.6 $0.95 1/15/20231,130,000 shares $921,967.00 -4.2%4.1%16.4 $0.82 12/30/20221,180,000 shares $782,104.00 +8.3%4.3%17.9 $0.66 12/15/20221,090,000 shares $775,971.00 +2.8%4.0%18.1 $0.71 11/30/20221,060,000 shares $873,864.00 -1.9%3.9%15.5 $0.82 11/15/20221,080,000 shares $950,508.00 -3.6%4.0%15.2 $0.88 10/31/20221,120,000 shares $967,680.00 No Change4.1%10.2 $0.86 10/15/20221,120,000 shares $958,048.00 -8.2%4.1%6.3 $0.86 9/30/20221,220,000 shares $1.18 million -0.8%4.5%5.3 $0.97 9/15/20221,230,000 shares $1.41 million -3.2%4.5%5 $1.15 8/31/20221,270,000 shares $1.35 million -5.9%8.1%4.4 $1.06 8/15/20221,350,000 shares $1.85 million -19.2%6.1%1.5 $1.37 7/31/20221,670,000 shares $1.50 million +21.9%9.2%1.8 $0.90 7/15/20221,370,000 shares $934,340.00 -9.3%7.5%1.6 $0.68 6/30/20221,510,000 shares $1.13 million -15.2%8.3%1.8 $0.75 6/15/20221,780,000 shares $1.34 million +17.1%9.8%2.1 $0.76 5/31/20221,520,000 shares $837,520.00 -13.1%5.3%1.8 $0.55 5/15/20221,750,000 shares $743,750.00 No Change6.1%6.7 $0.43 4/30/20221,750,000 shares $1.21 million -0.6%6.1%7.5 $0.69 4/15/20221,760,000 shares $1.39 million +1.2%6.1%7.3 $0.79 3/31/20221,740,000 shares $1.26 million +3.6%6.1%6.9 $0.72 3/15/20221,680,000 shares $924,840.00 -13.0%5.9%5.7 $0.55 2/28/20221,930,000 shares $1.58 million +19.1%6.7%6.2 $0.82 2/15/20221,620,000 shares $1.20 million -0.6%5.7%5.1 $0.74 1/31/20221,630,000 shares $1.17 million +1.2%5.4%4.4 $0.72 1/15/20221,610,000 shares $1.42 million -5.3%5.3%3.5 $0.88 12/31/20211,700,000 shares $1.69 million -6.1%N/A2.8 $1.00 12/15/20211,810,000 shares $2.03 million -13.4%6.0%1.1 $1.12 11/30/20212,090,000 shares $2.59 million -2.3%8.0%1.1 $1.24 11/15/20212,140,000 shares $3.32 million +9.2%8.2%1.2 $1.55 10/29/20211,960,000 shares $2.80 million -22.8%8.4%1.1 $1.43 10/15/20212,540,000 shares $3.73 million +15.5%10.8%1.5 $1.47 9/30/20212,200,000 shares $3.37 million +39.2%9.4%1.4 $1.53 9/15/20211,580,000 shares $2.73 million -8.7%6.7%1.1 $1.73 8/31/20211,730,000 shares $3.24 million -14.4%7.4%1.6 $1.87 8/13/20212,020,000 shares $3.72 million -4.3%8.6%1.6 $1.84 7/30/20212,110,000 shares $4.05 million +2.9%9.0%1.4 $1.92 7/15/20212,050,000 shares $4.12 million -10.1%8.7%1.3 $2.01 6/30/20212,280,000 shares $5.20 million -5.4%10.3%0.4 $2.28 6/15/20212,410,000 shares $6.17 million +5.7%10.9%0.4 $2.56 5/28/20212,280,000 shares $5.61 million -11.3%10.7%0.4 $2.46 5/14/20212,570,000 shares $5.83 million -17.4%12.2%0.5 $2.27 4/30/20213,110,000 shares $8.21 million -39.9%14.8%0.5 $2.64 4/15/20215,170,000 shares $17.22 million +138.3%24.8%0.7 $3.33DeFi Coin on Verge of Breakout! (Ad)What Smart Crypto Investors Are Doing Differently in 2025 Free book reveals how to navigate and thrive in today’s crypto market… Request your FREE copy of Crypto Revolution now. 3/31/20212,170,000 shares $5.82 million -4.4%10.4%0.7 $2.68 3/15/20212,270,000 shares $6.13 million -9.9%11.0%0.7 $2.70 2/26/20212,520,000 shares $6.40 million -17.7%15.9%0.5 $2.54 2/12/20213,060,000 shares $8.26 million -7.0%21.8%0.6 $2.70 1/29/20213,290,000 shares $6.58 million +12.3%25.4%0.7 $2.00 1/15/20212,930,000 shares $6.30 million +5.0%22.6%0.9 $2.15 12/31/20202,790,000 shares $5.38 million -26.8%21.5%1 $1.93 12/15/20203,810,000 shares $11.32 million +73.2%29.4%1.4 $2.97 11/30/20202,200,000 shares $4.73 million +5.3%18.2%3.4 $2.15 10/30/20201,940,000 shares $3.38 million -2.0%15.3%3.9 $1.74 10/15/20201,980,000 shares $3.45 million -1.0%16.5%4.2 $1.74 9/30/20202,000,000 shares $3.54 million +0.5%16.7%4.1 $1.77 9/15/20201,990,000 shares $3.88 million +4.7%16.6%3.8 $1.95 8/31/20201,900,000 shares $3.95 million +8.6%15.8%3.4 $2.08 8/14/20201,750,000 shares $4.25 million -0.6%18.7%2.9 $2.43 7/31/20201,760,000 shares $4.14 million -7.4%18.8%2.6 $2.35 7/15/20201,900,000 shares $4.45 million -9.5%21.8%4.4 $2.34 6/30/20202,100,000 shares $4.68 million +16.7%24.1%5.1 $2.23 6/15/20201,800,000 shares $4.99 million +0.6%20.6%4.8 $2.77 5/29/20201,790,000 shares $5.16 million +0.6%20.5%6.4 $2.88 5/15/20201,780,000 shares $5.30 million +5.3%20.4%5.5 $2.98 4/30/20201,690,000 shares $3.58 million +10.5%20.1%2.4 $2.12 4/15/20201,530,000 shares $3.35 million +3.4%19.3%2.1 $2.19 3/31/20201,480,000 shares $2.83 million +5.9%18.8%1.8 $1.91 3/13/20201,397,600 shares $2.74 million +0.6%17.7%4.7 $1.96 2/28/20201,390,000 shares $2.39 million +2.2%17.6%1.6 $1.72 2/14/20201,360,000 shares $3.67 million +6.3%31.3%1.7 $2.70 1/31/20201,280,000 shares $4.25 million -2.3%33.9%1.8 $3.32 VTVT Short Interest - Frequently Asked Questions What is vTv Therapeutics' current short interest? Short interest is the volume of vTv Therapeutics shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 16,900 shares of VTVT short. 1.14% of vTv Therapeutics' shares are currently sold short. Learn More on vTv Therapeutics' current short interest. What is a good short interest ratio for vTv Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTVT shares currently have a short interest ratio of 1.0. Learn More on vTv Therapeutics's short interest ratio. What is a good short interest percentage for vTv Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.14% of vTv Therapeutics' floating shares are currently sold short. What is vTv Therapeutics' float size? vTv Therapeutics currently has issued a total of 3,190,000 shares. Some of vTv Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. vTv Therapeutics currently has a public float of 1,480,000 shares. How does vTv Therapeutics' short interest compare to its competitors? 1.14% of vTv Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to vTv Therapeutics: Acrivon Therapeutics, Inc. (5.37%), Coherus BioSciences, Inc. (26.66%), ADC Therapeutics SA (5.03%), Vaxart, Inc. (5.09%), Nkarta, Inc. (14.10%), Greenwich LifeSciences, Inc. (9.42%), Bright Minds Biosciences Inc. (3.50%), Checkpoint Therapeutics, Inc. (21.14%), Adaptimmune Therapeutics plc (2.15%), Puma Biotechnology, Inc. (8.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short vTv Therapeutics stock? Short selling VTVT is an investing strategy that aims to generate trading profit from vTv Therapeutics as its price is falling. VTVT shares are trading up $0.79 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against vTv Therapeutics? A short squeeze for vTv Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VTVT, which in turn drives the price of the stock up even further. How often is vTv Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTVT, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Acrivon Therapeutics Short Interest Coherus BioSciences Short Interest ADC Therapeutics Short Interest Vaxart Short Interest Nkarta Short Interest Greenwich LifeSciences Short Interest Bright Minds Biosciences Short Interest Checkpoint Therapeutics Short Interest Adaptimmune Therapeutics Short Interest Puma Biotechnology Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTVT) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
